The Indian Supreme Court's landmark decision to uphold India's Patents Act in the face of the seven-year challenge by Swiss pharmaceutical company Novartis is a major victory for patients' access to affordable medicines in developing countries.
Here, MSF's Leena Menghaney responds outside the Supreme Court after the verdict was read on 1 April.